Reply: “Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases”
Introduction
References
- Fürstenwerth, H. Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases, Int. J. Mol. Sci. 2018, 19, 1948. Int. J. Mol. Sci. 2019, 20, 505. [Google Scholar] [CrossRef] [PubMed]
- Simonini, M.; Casanova, P.; Citterio, L.; Messaggio, E.; Lanzani, C.; Manunta, P. Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases. Int. J. Mol. Sci. 2018, 19, 1948. [Google Scholar] [CrossRef] [PubMed]
- Hamlyn, J.M.; Blaustein, M.P.; Bova, S.; DuCharme, D.W.; Harris, D.W.; Mandel, F.; Mathews, W.R.; Ludens, J.H. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 1991, 88, 6259–6263. [Google Scholar] [CrossRef] [PubMed]
- Kawamura, A.; Guo, J.; Itagaki, Y.; Bell, C.; Wang, Y.; Haupert, G.T.; Magil, S.; Gallagher, R.T.; Berova, N.; Nakanishi, K. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. USA 1999, 96, 6654–6659. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schneider, R.; Wray, V.; Nimtz, M.; Lehmann, W.D.; Kirch, U.; Antolovic, R.; Schoner, W. Bovine adrenals contain, in addition to ouabain, a second inhibitor of the sodium pump. J. Biol. Chem. 1998, 273, 784–792. [Google Scholar] [CrossRef] [PubMed]
- Lewis, L.K.; Yandle, T.G.; Hilton, P.J.; Jensen, B.P.; Begg, E.J.; Nicholls, M.G. Endogenous Ouabain is Not Ouabain. Hypertension 2014, 64, 680–683. [Google Scholar] [CrossRef]
- Jacobs, B.E.; Liu, Y.; Pulina, M.V.; Golovina, V.A.; Hamlyn, J.M. Normal pregnancy: Mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, H1317–H1329. [Google Scholar] [CrossRef]
- Hamlyn, J.M.; Linde, C.I.; Gao, J.; Huang, B.S.; Golovina, V.A.; Blaustein, M.P.; Leenen, F.H. Neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin II: A new axis in long term blood pressure control. PLoS ONE 2014. [Google Scholar] [CrossRef]
- Komiyama, Y.; Nishimura, N.; Munakata, M.; Mori, T.; Okuda, K.; Nishino, N.; Hirose, S.; Kosaka, C.; Masuda, M.; Takahashi, H. Identification of endogenous ouabain in culture supernatant of PC12 cells. J. Hypertens. 2001, 19, 229–236. [Google Scholar] [CrossRef]
- Baecher, S.; Kroiss, M.; Fassnacht, M.; Vogeser, M. No endogenous ouabain is detectable in human plasma by ultra-sensitive UPLC-MS/MS. Clin. Chim. Acta 2014, 431, 87–92. [Google Scholar] [CrossRef]
- Blaustein, M.P. Letter to the Editor concerning Baecher et al. Clin. Chim. Acta 2015, 448, 248–249. [Google Scholar] [CrossRef] [PubMed]
- Hamlyn, J.M.; Blaustein, M.P. Endogenous Ouabain: Recent Advances and Controversies. Hypertension 2016, 68, 526–532. [Google Scholar] [PubMed]
- Manunta, P.; Ferrandi, M.; Bianchi, G.; Hamlyn, J.M. Endogenous ouabain in cardiovascular function and disease. J. Hypertens. 2009, 27, 9–18. [Google Scholar] [CrossRef] [PubMed]
- Manunta, P.; Stella, P.; Rivera, R.; Ciurlino, D.; Cusi, D.; Ferrandi, M.; Hamlyn, J.M.; Bianchi, G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999, 34, 450–456. [Google Scholar] [CrossRef]
- Manunta, P.; Hamilton, B.P.; Hamlyn, J.M. Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. AJP Regul. Integr. Comp. Physiol. 2006, 290, R553–R559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pitzalis, M.V.; Hamlyn, J.M.; Messaggio, E.; Iacoviello, M.; Forleo, C.; Romito, R.; de Tommasi, E.; Rizzon, P.; Bianchi, G.; Manunta, P. Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy. Eur. J. Heart Fail. 2006, 8, 179–186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tripodi, G.; Citterio, L.; Kouznetsova, T.; Lanzani, C.; Florio, M.; Modica, R.; Messaggio, E.; Hamlyn, J.M.; Zagato, L.; Bianchi, G.; et al. Steroid biosynthesis and renal excretion in human essential hypertension: Association with blood pressure and endogenous ouabain. Am. J. Hypertens. 2009, 22, 357–363. [Google Scholar] [CrossRef]
- Hamlyn, J.M.; Manunta, P. Endogenous Cardiotonic Steroids in Kidney Failure: A Review and an Hypothesis. Adv. Chronic Kidney Dis. 2015, 22, 232–244. [Google Scholar] [CrossRef] [Green Version]
- Liu, M.; Li, Y.; Citterio, L.; Huang, Q.F.; Zeng, W.F.; Sheng, C.S.; Wei, F.F.; Dong, Q.; Li, G.L.; Kang, Y.Y.; et al. A functional common polymorphism of the ABCB1 gene is associated with chronic kidney disease and hypertension in Chinese. Am. J. Hypertens. 2013, 26, 1428–1436. [Google Scholar] [CrossRef]
- Lanzani, C.; Citterio, L.; Glorioso, N.; Manunta, P.; Tripodi, G.; Salvi, E.; Carpini, S.D.; Ferrandi, M.; Messaggio, E.; Staessen, J.A.; et al. Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: Clinical studies. Sci. Transl. Med. 2010, 2, 59ra87. [Google Scholar] [CrossRef]
- Iatrino, R.; Lanzani, C.; Bignami, E.; Casamassima, N.; Citterio, L.; Meroni, R.; Zagato, L.; Zangrillo, A.; Alfieri, O.; Fontana, S.; et al. Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury. Am. J. Kidney Dis. 2019, in press. [Google Scholar] [CrossRef] [PubMed]
- Simonini, M.; Lanzani, C.; Bignami, E.; Casamassima, N.; Frati, E.; Meroni, R.; Messaggio, E.; Alfieri, O.; Hamlyn, J.; Body, S.C.; et al. A new clinical multivariable model that predicts postoperative acute kidney injury: Impact of endogenous ouabain. Nephrol. Dial. Transplant. 2014, 29, 1696–1701. [Google Scholar] [CrossRef] [PubMed]
- Bignami, E.; Casamassima, N.; Frati, E.; Lanzani, C.; Corno, L.; Alfieri, O.; Gottlieb, S.; Simonini, M.; Shah, K.B.; Mizzi, A.; et al. Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients. Crit. Care Med. 2013, 41, 744–755. [Google Scholar] [CrossRef] [PubMed]
- Ferrandi, M.; Ferrandi, M.; Molinari, I.; Molinari, I.; Rastaldi, M.P.; Rastaldi, M.P.; Ferrari, P.; Ferrari, P.; Bianchi, G.; Bianchi, G.; et al. Rostafuroxin Protects from Podocyte Injury and Proteinuria Induced by Adducin Genetic Variants and Ouabain. J. Pharmacol. Exp. Ther. 2014, 351, 278–287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Manunta, P.; Hamilton, J.; Rogowski, A.C.; Hamilton, B.P.; Hamlyn, J.M. Chronic hypertension induced by ouabain but not digoxin in the rat: Antihypertensive effect of digoxin and digitoxin. Hypertens. Res. 2000, 23, S77–S85. [Google Scholar] [CrossRef] [PubMed]
- Yuan, C.M.; Manunta, P.; Hamlyn, J.M.; Chen, S.; Bohen, E.; Yeun, J.; Haddy, F.J.; Pamnani, M.B. Long-term ouabain administration produces hypertension in rats. Hypertension 1993, 22, 178–187. [Google Scholar] [CrossRef] [PubMed]
- Weiss, D.N.; Podberesky, D.J.; Heidrich, J.; Blaustein, M.P. Nanomolar ouabain augments caffeine-evoked contractions in rat arteries. Am. J. Physiol. 1993, 265, C1443–C1448. [Google Scholar] [CrossRef] [PubMed]
- Villa, L.; Buono, R.; Ferrandi, M.; Molinari, I.; Benigni, F.; Bettiga, A.; Colciago, G.; Ikehata, M.; Messaggio, E.; Rastaldi, M.P.; et al. Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury. Int. J. Mol. Sci. 2016, 17, 1728. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, H.; Yoshika, M.; Komiyama, Y.; Nishimura, M. The central mechanism underlying hypertension: A review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain. Hypertens. Res. 2011, 34, 1147–1160. [Google Scholar] [CrossRef]
- Jansson, K.; Nguyen, A.-N.T.; Magenheimer, B.S.; Reif, G.A.; Aramadhaka, L.R.; Bello-Reuss, E.; Wallace, D.P.; Calvet, J.P.; Blanco, G. Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Am. J. Physiol. Ren. Physiol. 2012, 303, F982–F990. [Google Scholar] [CrossRef]
- Buzaglo, N.; Golomb, M.; Rosen, H.; Beeri, R.; Ami, H.C.; Langane, F.; Pierre, S.; Lichtstein, D. Augmentation of Ouabain-Induced Increase in Heart Muscle Contractility by Akt Inhibitor MK-2206. J. Cardiovasc. Pharmacol. Ther. 2018. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Simonini, M.; Casanova, P.; Citterio, L.; Messaggio, E.; Lanzani, C.; Manunta, P. Reply: “Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases”. Int. J. Mol. Sci. 2019, 20, 542. https://doi.org/10.3390/ijms20030542
Simonini M, Casanova P, Citterio L, Messaggio E, Lanzani C, Manunta P. Reply: “Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases”. International Journal of Molecular Sciences. 2019; 20(3):542. https://doi.org/10.3390/ijms20030542
Chicago/Turabian StyleSimonini, Marco, Paola Casanova, Lorena Citterio, Elisabetta Messaggio, Chiara Lanzani, and Paolo Manunta. 2019. "Reply: “Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases”" International Journal of Molecular Sciences 20, no. 3: 542. https://doi.org/10.3390/ijms20030542